Member of the New York and Connecticut Bars
Tom advises U.S. and international clients on the antitrust aspects of multinational mergers clearances and defends clients in criminal price-fixing investigations and private antitrust litigation. He regularly appears on behalf of clients before the U.S. Department of Justice and Federal Trade Commission. His practice includes advising clients on the antitrust aspects of a broad range of matters, including intellectual property licensing, cooperation with competitors, distribution arrangements, price discrimination issues, and U.S. and global competition law compliance programs.
Most recently, he has advised a major Japanese company on its proposed joint venture with a chemical company to acquire a high performance chemical business in U.S. and global merger control proceedings, Novartis on its oncology and vaccines transactions with GSK and Siemens on its acquisitions of the Rolls-Royce Energy aero-derivative gas turbine business and the Invensys rail business. Previously he acted for Glencore on its acquisition of Xstrata and Deutsche Börse on its planned merger with NYSE Euronext. He was also lead counsel for Air France KLM in the air cargo cartel cases. Tom practices in Linklaters’ New York and Washington offices.
Tom is a member of the Antitrust Section of the American Bar Association and is recognized in Chambers USA and Legal 500 U.S.
2005 to date Partner, Linklaters, New York
2004 - 2005 Counsel, Shearman & Sterling LLP, New York
1994 - 2004 Associate, Shearman & Sterling LLP, New York
1994 - Fordham University School of Law, J.D., Managing Editor, Fordham Law Review
1989 - College of the Holy Cross, B.A., Economics
Co-author, “Setting Sail From the Safe Harbor - When an Analyst Call Triggers an Antitrust Probe”, Corporate Counsel, 21 January 2011